CorEvitas is now part of Thermo Fisher Scientific. Read More.
NOW ENROLLING
Participating Sites
CorEvitas has clinical sites across the U.S. and Canada, and we are always interested in expanding the registry for qualified sites. If you are interested in participating, we invite you to complete a brief feasibility survey.
The Alopecia Areata (AA) Registry is a prospective, observational cohort study for subjects with AA under the care of a dermatology provider. The registry is designed to study the natural history of AA, the real-world effectiveness and safety of medications used in the treatment of AA, and drug utilization treatment patterns.
Structured clinical data are collected approximately every 6 months at regular office visits from patients and providers at the time of routine clinical encounters.
A minimum of 5,000 patients and 100 clinical sites in the U.S. and Canada will be recruited to participate in the CorEvitas AA Registry.
